An MRAS, SHOC2, and SCRIB Complex Coordinates ERK Pathway Activation with Polarity and Tumorigenic Growth

被引:93
|
作者
Young, Lucy C. [1 ]
Hartig, Nicole [1 ]
Munoz-Alegre, Marta [1 ]
Oses-Prieto, Juan A. [2 ]
Durdu, Sevi [3 ]
Bender, Sabine [1 ]
Vijayakumar, Vineetha [4 ]
Rudan, Matteo Vietri [1 ]
Gewinner, Christina [1 ]
Henderson, Stephen [1 ]
Jathoul, Amit P. [1 ]
Ghatrora, Rupinder [5 ,6 ]
Lythgoe, Mark F. [5 ,6 ]
Burlingame, Alma L. [2 ]
Rodriguez-Viciana, Pablo [1 ]
机构
[1] UCL, UCL Canc Inst, London WC1E 6BT, England
[2] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
[3] European Mol Biol Lab, D-69117 Heidelberg, Germany
[4] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England
[5] UCL, UCL Ctr Adv Biomed Imaging, Div Med, London WC1E 6BT, England
[6] UCL, Inst Child Hlth, London WC1E 6BT, England
关键词
RICH REPEAT PROTEIN; CELL POLARITY; MESENCHYMAL TRANSITION; M-RAS; CANCER; PHOSPHATASE-1; FAMILY; EXPRESSION; MIGRATION; EFFECTOR;
D O I
10.1016/j.molcel.2013.10.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SHOC2 is mutated in Noonan syndrome and plays a key role in the activation of the ERK-MAPK pathway, which is upregulated in the majority of human cancers. SHOC2 functions as a PP1-regulatory protein and as an effector of MRAS. Here we show that SHOC2 and MRAS form a complex with SCRIB, a polarity protein with tumor suppressor properties. SCRIB functions as a PP1-regulatory protein and antagonizes SHOC2-mediated RAF dephosphorylation through a mechanism involving competition for PP1 molecules within the same macromolecular complex. SHOC2 function is selectively required for the malignant properties of tumor cells with mutant RAS, and both MRAS and SHOC2 play a key role in polarized migration. We propose that MRAS, through its ability to recruit a complex with paradoxical components, coordinates ERK pathway spatiotemporal dynamics with polarity and that this complex plays a key role during tumorigenic growth.
引用
收藏
页码:679 / 692
页数:14
相关论文
共 44 条
  • [1] An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growth
    Young, Lucy C.
    Hartig, Nicole
    Munoz-Alegre, Marta
    Oses-Prieto, Juan A.
    Durdu, Sevi
    Bender, Sabine
    Vijayakumar, Vineetha
    Rudan, Matteo Vietri
    Gewinner, Christina
    Henderson, Stephen
    Jathoul, Amit P.
    Ghatrora, Rupinder
    Lythgoe, Mark F.
    Burlingame, Alma L.
    Rodriguez-Viciana, Pablo
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [2] MRAS and SHOC2 interact with SCRIB and coordinate ERK pathway activation with polarity and tumorigenic growth
    Young, Lucy C.
    Hartig, Nicole
    Munoz-Alegre, Marta
    Oses-Prieto, Juan A.
    Durdu, Sevi
    Bender, Sabine
    Vijakumar, Vineetha
    Rudan, Matteo Vietri
    Gewinner, Christina
    Jathoul, Amit P.
    Ghatrora, Rupinder
    Lythgoe, Mark L.
    Burlingame, Alma L.
    Rodriguez-Viciana, Pablo
    CANCER RESEARCH, 2015, 75
  • [3] Structure of the MRAS–SHOC2–PP1C phosphatase complex
    Zachary J. Hauseman
    Michelle Fodor
    Anxhela Dhembi
    Jessica Viscomi
    David Egli
    Melusine Bleu
    Stephanie Katz
    Eunyoung Park
    Dong Man Jang
    Kathryn A. Porter
    Fabian Meili
    Hongqiu Guo
    Grainne Kerr
    Sandra Mollé
    Camilo Velez-Vega
    Kim S. Beyer
    Giorgio G. Galli
    Saveur-Michel Maira
    Travis Stams
    Kirk Clark
    Michael J. Eck
    Luca Tordella
    Claudio R. Thoma
    Daniel A. King
    Nature, 2022, 609 : 416 - 423
  • [4] SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamics
    del Rio, Isabel Boned
    Young, Lucy C.
    Sari, Sibel
    Jones, Greg G.
    Ringham-Terry, Benjamin
    Hartig, Nicole
    Rejnowicz, Ewa
    Lei, Winnie
    Bhamra, Amandeep
    Surinova, Silvia
    Rodriguez-Viciana, Pablo
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (27) : 13330 - 13339
  • [5] Shoc2 Mediates Hematopoietic Signals of the ERK1/2 Pathway
    Jang, Hyein
    Jang, Eun Ryoung
    Morris, Ann
    Forbes-Osborne, Marrie
    Galperin, Emilia
    FASEB JOURNAL, 2017, 31
  • [6] Structure of the SHOC2–MRAS–PP1C complex provides insights into RAF activation and Noonan syndrome
    Daniel A. Bonsor
    Patrick Alexander
    Kelly Snead
    Nicole Hartig
    Matthew Drew
    Simon Messing
    Lorenzo I. Finci
    Dwight V. Nissley
    Frank McCormick
    Dominic Esposito
    Pablo Rodriguez-Viciana
    Andrew G. Stephen
    Dhirendra K. Simanshu
    Nature Structural & Molecular Biology, 2022, 29 : 966 - 977
  • [7] Structure–function analysis of the SHOC2–MRAS–PP1C holophosphatase complex
    Jason J. Kwon
    Behnoush Hajian
    Yuemin Bian
    Lucy C. Young
    Alvaro J. Amor
    James R. Fuller
    Cara V. Fraley
    Abbey M. Sykes
    Jonathan So
    Joshua Pan
    Laura Baker
    Sun Joo Lee
    Douglas B. Wheeler
    David L. Mayhew
    Nicole S. Persky
    Xiaoping Yang
    David E. Root
    Anthony M. Barsotti
    Andrew W. Stamford
    Charles K. Perry
    Alex Burgin
    Frank McCormick
    Christopher T. Lemke
    William C. Hahn
    Andrew J. Aguirre
    Nature, 2022, 609 : 408 - 415
  • [8] The SHOC2 phosphatase complex as a therapeutic target for ERK-pathway inhibition in RAS-driven tumors.
    Jones, Greg G.
    Del Rio, Isabel Boned
    Sari, Sibel
    Sekerim, Aysen
    Young, Lucy C.
    Hartig, Nicole
    El-Bahrawy, Mona A.
    Molina-Arcas, Miriam
    Downward, Julian
    Rodriguez-Viciana, Pablo
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 65 - 66
  • [9] The expression of congenital Shoc2 variants induces AKT-dependent crosstalk activation of the ERK1/2 pathway
    Wilson, Patricia G.
    Abdelmoti, Lina
    Gao, Tianyan
    Galperin, Emilia
    HUMAN MOLECULAR GENETICS, 2024, 33 (18) : 1592 - 1604
  • [10] Selective contribution of the SHOC2 phosphatase complex to ERK pathway dynamics highlights its potential as a therapeutic target.
    del Rio, Isabel Boned
    Young, Lucy C.
    Sari, Sibel
    Jones, Greg G.
    Bhamra, Amandeep
    Surinova, Silvia
    Rodriguez-Viciana, Pablo
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 32 - 32